chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 64.0
Sex: F
Vaccine: COVID19
Symptoms: Tachycardia
Clinical narrative: Pfizer Dose 1 6/24/21 (lot NA) Pfizer Dose 2 7/16/21 (lot NA) COVID Positive 1/16/22 COVID Positive 1/18/22  1/18/22: 65-year-old lady who presented to the emergency room with a history of generalized fatigue and palpitation following infusion of antibody for the treatment of COVID.  The patient was diagnosed with COVID 2 days ago on Sunday, 01/16/2022, and was scheduled to get her antibody infusion today.  After the infusion, the patient was noted to have some episode of heart racing, complaining of fatigue.  She was sent to the emergency room for further evaluation.  In the emergency room, she was noted to be tachycardic up to 150.  She did not, however, desaturate.  The patient had a CT of the chest done that shows bilateral pulmonary embolism. Currently, she denies chest pain and denied nausea.  1/21/22: 65-year-old woman who presented complaints of chest discomfort and shortness of breath immediately following monoclonal and antibody infusion for recently diagnosed COVID-19 infection.  She was brought to the emergency department where she was found to be in atrial flutter.  Neatly on CT pulmonary angio angiogram revealed saddle  pulmonary embolism with areas of right middle and lower lobe infarcts.  She was admitted to the hospitalist Service, underwent transthoracic echocardiogram with no evidence of right ventricular strain.  Therapeutic anticoagulation was started with IV heparin and continued for 72 hours before being transition to oral Eliquis for anticoagulation.  Hospital course was remarkable for brief episode of scant hemoptysis and pleurisy which resolved prior to discharge.  No further episodes of arrhythmias were noted during hospital course.  She is in stable medical condition at the time of discharge.
Age: 24.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, Ear pain, Influenza virus test, Malaise, Nasal congestion
Clinical narrative: Breakthrough covid case. Pt presented to ER on 6/21/22 with c/o of right ear pain, nasal congestion, malaise. Hx of Pfizer vaccine x 3. DC home.
Age: 24.0
Sex: F
Vaccine: COVID19
Symptoms: SARS-CoV-2 test positive, Vaccine breakthrough infection
Clinical narrative: Breakthrough covid case. Pt presented to ER on 6/21/22 with c/o of right ear pain, nasal congestion, malaise. Hx of Pfizer vaccine x 3. DC home.
Age: 13.0
Sex: F
Vaccine: MNQ, TD
Symptoms: Blood pressure decreased, Cold sweat, Heart rate decreased, Hyperhidrosis, Loss of consciousness
Clinical narrative: Sweaty, clammy, decreased BP (80s/50s), decreased HR (40s), loss of consciousness, decreased O2, vasovagal response/possible decorticate seizure. Oxygen administered, transported to emergency department for further evaluation.
Age: 13.0
Sex: F
Vaccine: MNQ, TD
Symptoms: Oxygen saturation decreased, Presyncope
Clinical narrative: Sweaty, clammy, decreased BP (80s/50s), decreased HR (40s), loss of consciousness, decreased O2, vasovagal response/possible decorticate seizure. Oxygen administered, transported to emergency department for further evaluation.
Age: 57.0
Sex: M
Vaccine: COVID19
Symptoms: Allergy test, Deafness, Diplopia, Dizziness, Electronystagmogram
Clinical narrative: Dizziness, spinning world, memory issues, ringing ears, hearing loss, double vision, extreme waves of tiredness
Age: 57.0
Sex: M
Vaccine: COVID19
Symptoms: Fatigue, Memory impairment, Tinnitus, Vertigo
Clinical narrative: Dizziness, spinning world, memory issues, ringing ears, hearing loss, double vision, extreme waves of tiredness
Age: 32.0
Sex: M
Vaccine: COVID19
Symptoms: Expired product administered, Product storage error
Clinical narrative: Pfizer gray cap vaccine was punctured on 6/26/22 at 10:45 am and two doses were drawn and administered. The vaccine was not disposed of at the end of business day on 6/26/22. On 6/27/22 we gave an additional dose that came from the same vial. The vial had been expired (per storage conditions) since 10:45 pm on 6/26/22. The dose was drawn up and then administered at about 6:20 pm on 6/27/22. Upon calling Pfizer, they stated that they only have data to show stability for up to 24 hours after first puncture when the vial is held between 28 and 86 degrees Fahrenheit. Therefore, according to the CDC, the dose should be repeated immediately with no minimum interval. We have left a message on the patient's voicemail to have them call us back regarding their vaccination. Upon a call back, we will explain the discrepancy and recommend re-vaccination immediately. No adverse events have been reported yet.
Age: 30.0
Sex: F
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: The vaccine expiration date was identified to expire on June 22, 2021, but the manufacturer expiration date was February 25, 2021.  Based on the information learned, County Health took the following steps: ? Contacted Moderna for guidance and based on Moderna data, the Moderna Medical Information team provided the following information:  o ?The vaccine administered on March 4, 2021 through March 10, 2021 from lot number 025J20-2A maintained the activity necessary to protect against the SARS-CoV-2 (COVID-19) virus at time of administration.?  ? Contacted a county medical director and based on this information from Moderna, no re-vaccination is needed.
Age: 75.0
Sex: F
Vaccine: COVID19
Symptoms: Dermatitis contact, Rash erythematous
Clinical narrative: I started having red rashes arise and I wasn't certain when it started what was affecting me. And this went on for weeks, I treated it with cortisone cream, BENADRYL, and they would after a few days subside. But they kept coming back. I had them on my face and lower neck area and on my upper arm. I went to a Dermatologist and she thought it was some kind of contact dermatitis. She gave me a couple of prescriptions and scalp foam. After the 4th COVID-19 shot I got a really red rash on my forearm from touching a mat at the gym. After hair coloring (something I did for 10 years), now every time after I get a big red rash around my hairline. It's some form of contact reaction that I can just get when I touch certain things. The only thing I can pin it to because I've never had any allergies is the vaccination because that's the only new change in my life.
Age: 55.0
Sex: F
Vaccine: COVID19
Symptoms: Blood pressure increased, COVID-19, COVID-19 pneumonia, Chest X-ray abnormal, Chills
Clinical narrative: Pfizer Dose 1 4/16/21 (lot NA) Pfizer Dose 2 5/7/21 (EW0183) Pfizder Dose 3 9/21/21 (lot NA) COVID Positive 1/31/22  1/31/22: The patient known to have lung transplant due to pulmonary fibrosis from fungal infection 2010 immunosuppressive therapy, exposed to COVID patients on Thursday, start on Saturday to have nausea and vomiting and headache with watery diarrhea and shortness of breath with dry cough, episodes of fever and chills with generalized magnus.  No chest pain or dizziness.  She is compliant on her medications.   At emergency she was hypoxic required 2 L of oxygen, her COVID-19 PCR test came back positive, her other labs unremarkable.  Chest x-ray done and show mild bronchial like infiltration without focal consolidations.  At ED she received azithromycin and ceftriaxone.   The pulmonologist at a HCF consulted, Dr. recommend Sotrovimab infusion and dexamethasone, use remdesivir if Sotrovimab not available, the patient accepted at another HCF pending bed availability.  2/3/22: The patient known to have lung fibrosis secondary to chronic fungal infection status post right Last Plantation on immunosuppressive therapy, presented with COVID-19 pneumonitis, she had cough with mild shortness of breath with normal oxygenation room air, chest exam initially mild wheezing then resolved with the therapy, she had nausea and vomiting and diarrhea which improved gradually, her blood pressure was elevated then controlled better.  Her labs show normal inflammatory markers and CBC however she has immunosuppressive therapy, discussed with her pulmonologist/lung transplant team, recommend to monitor her tacrolimus level and the goal between 8 and 10, pending results back, agree on dexamethasone and remdesivir.  The patient currently hemodynamically stable not in distress with normal inflammatory markers, will discharge her today after receiving the 3rd dose of from the severe and follow-up with her pulmonologist next week.
Age: 55.0
Sex: F
Vaccine: COVID19
Symptoms: Cough, Diarrhoea, Dyspnoea, Exposure to SARS-CoV-2, Full blood count normal
Clinical narrative: Pfizer Dose 1 4/16/21 (lot NA) Pfizer Dose 2 5/7/21 (EW0183) Pfizder Dose 3 9/21/21 (lot NA) COVID Positive 1/31/22  1/31/22: The patient known to have lung transplant due to pulmonary fibrosis from fungal infection 2010 immunosuppressive therapy, exposed to COVID patients on Thursday, start on Saturday to have nausea and vomiting and headache with watery diarrhea and shortness of breath with dry cough, episodes of fever and chills with generalized magnus.  No chest pain or dizziness.  She is compliant on her medications.   At emergency she was hypoxic required 2 L of oxygen, her COVID-19 PCR test came back positive, her other labs unremarkable.  Chest x-ray done and show mild bronchial like infiltration without focal consolidations.  At ED she received azithromycin and ceftriaxone.   The pulmonologist at a HCF consulted, Dr. recommend Sotrovimab infusion and dexamethasone, use remdesivir if Sotrovimab not available, the patient accepted at another HCF pending bed availability.  2/3/22: The patient known to have lung fibrosis secondary to chronic fungal infection status post right Last Plantation on immunosuppressive therapy, presented with COVID-19 pneumonitis, she had cough with mild shortness of breath with normal oxygenation room air, chest exam initially mild wheezing then resolved with the therapy, she had nausea and vomiting and diarrhea which improved gradually, her blood pressure was elevated then controlled better.  Her labs show normal inflammatory markers and CBC however she has immunosuppressive therapy, discussed with her pulmonologist/lung transplant team, recommend to monitor her tacrolimus level and the goal between 8 and 10, pending results back, agree on dexamethasone and remdesivir.  The patient currently hemodynamically stable not in distress with normal inflammatory markers, will discharge her today after receiving the 3rd dose of from the severe and follow-up with her pulmonologist next week.
Age: 55.0
Sex: F
Vaccine: COVID19
Symptoms: Headache, Hypoxia, Immunosuppressant drug therapy, Inflammatory marker test, Laboratory test normal
Clinical narrative: Pfizer Dose 1 4/16/21 (lot NA) Pfizer Dose 2 5/7/21 (EW0183) Pfizder Dose 3 9/21/21 (lot NA) COVID Positive 1/31/22  1/31/22: The patient known to have lung transplant due to pulmonary fibrosis from fungal infection 2010 immunosuppressive therapy, exposed to COVID patients on Thursday, start on Saturday to have nausea and vomiting and headache with watery diarrhea and shortness of breath with dry cough, episodes of fever and chills with generalized magnus.  No chest pain or dizziness.  She is compliant on her medications.   At emergency she was hypoxic required 2 L of oxygen, her COVID-19 PCR test came back positive, her other labs unremarkable.  Chest x-ray done and show mild bronchial like infiltration without focal consolidations.  At ED she received azithromycin and ceftriaxone.   The pulmonologist at a HCF consulted, Dr. recommend Sotrovimab infusion and dexamethasone, use remdesivir if Sotrovimab not available, the patient accepted at another HCF pending bed availability.  2/3/22: The patient known to have lung fibrosis secondary to chronic fungal infection status post right Last Plantation on immunosuppressive therapy, presented with COVID-19 pneumonitis, she had cough with mild shortness of breath with normal oxygenation room air, chest exam initially mild wheezing then resolved with the therapy, she had nausea and vomiting and diarrhea which improved gradually, her blood pressure was elevated then controlled better.  Her labs show normal inflammatory markers and CBC however she has immunosuppressive therapy, discussed with her pulmonologist/lung transplant team, recommend to monitor her tacrolimus level and the goal between 8 and 10, pending results back, agree on dexamethasone and remdesivir.  The patient currently hemodynamically stable not in distress with normal inflammatory markers, will discharge her today after receiving the 3rd dose of from the severe and follow-up with her pulmonologist next week.
Age: 55.0
Sex: F
Vaccine: COVID19
Symptoms: Lung infiltration, Nausea, Pyrexia, SARS-CoV-2 test positive, Vomiting
Clinical narrative: Pfizer Dose 1 4/16/21 (lot NA) Pfizer Dose 2 5/7/21 (EW0183) Pfizder Dose 3 9/21/21 (lot NA) COVID Positive 1/31/22  1/31/22: The patient known to have lung transplant due to pulmonary fibrosis from fungal infection 2010 immunosuppressive therapy, exposed to COVID patients on Thursday, start on Saturday to have nausea and vomiting and headache with watery diarrhea and shortness of breath with dry cough, episodes of fever and chills with generalized magnus.  No chest pain or dizziness.  She is compliant on her medications.   At emergency she was hypoxic required 2 L of oxygen, her COVID-19 PCR test came back positive, her other labs unremarkable.  Chest x-ray done and show mild bronchial like infiltration without focal consolidations.  At ED she received azithromycin and ceftriaxone.   The pulmonologist at a HCF consulted, Dr. recommend Sotrovimab infusion and dexamethasone, use remdesivir if Sotrovimab not available, the patient accepted at another HCF pending bed availability.  2/3/22: The patient known to have lung fibrosis secondary to chronic fungal infection status post right Last Plantation on immunosuppressive therapy, presented with COVID-19 pneumonitis, she had cough with mild shortness of breath with normal oxygenation room air, chest exam initially mild wheezing then resolved with the therapy, she had nausea and vomiting and diarrhea which improved gradually, her blood pressure was elevated then controlled better.  Her labs show normal inflammatory markers and CBC however she has immunosuppressive therapy, discussed with her pulmonologist/lung transplant team, recommend to monitor her tacrolimus level and the goal between 8 and 10, pending results back, agree on dexamethasone and remdesivir.  The patient currently hemodynamically stable not in distress with normal inflammatory markers, will discharge her today after receiving the 3rd dose of from the severe and follow-up with her pulmonologist next week.
Age: 55.0
Sex: F
Vaccine: COVID19
Symptoms: Wheezing
Clinical narrative: Pfizer Dose 1 4/16/21 (lot NA) Pfizer Dose 2 5/7/21 (EW0183) Pfizder Dose 3 9/21/21 (lot NA) COVID Positive 1/31/22  1/31/22: The patient known to have lung transplant due to pulmonary fibrosis from fungal infection 2010 immunosuppressive therapy, exposed to COVID patients on Thursday, start on Saturday to have nausea and vomiting and headache with watery diarrhea and shortness of breath with dry cough, episodes of fever and chills with generalized magnus.  No chest pain or dizziness.  She is compliant on her medications.   At emergency she was hypoxic required 2 L of oxygen, her COVID-19 PCR test came back positive, her other labs unremarkable.  Chest x-ray done and show mild bronchial like infiltration without focal consolidations.  At ED she received azithromycin and ceftriaxone.   The pulmonologist at a HCF consulted, Dr. recommend Sotrovimab infusion and dexamethasone, use remdesivir if Sotrovimab not available, the patient accepted at another HCF pending bed availability.  2/3/22: The patient known to have lung fibrosis secondary to chronic fungal infection status post right Last Plantation on immunosuppressive therapy, presented with COVID-19 pneumonitis, she had cough with mild shortness of breath with normal oxygenation room air, chest exam initially mild wheezing then resolved with the therapy, she had nausea and vomiting and diarrhea which improved gradually, her blood pressure was elevated then controlled better.  Her labs show normal inflammatory markers and CBC however she has immunosuppressive therapy, discussed with her pulmonologist/lung transplant team, recommend to monitor her tacrolimus level and the goal between 8 and 10, pending results back, agree on dexamethasone and remdesivir.  The patient currently hemodynamically stable not in distress with normal inflammatory markers, will discharge her today after receiving the 3rd dose of from the severe and follow-up with her pulmonologist next week.
Age: 49.0
Sex: M
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: The vaccine expiration date was identified to expire on June 22, 2021, but the manufacturer expiration date was February 25, 2021.  Based on the information learned, facility took the following steps: ? Contacted Moderna for guidance and based on Moderna data, the Moderna medical information team provided the following information:  o ?The vaccine administered on March 4, 2021 through March 10, 2021 from lot number 025J20-2A maintained the activity necessary to protect against the SARS-CoV-2 (COVID-19) virus at time of administration.?  ? Contacted a county medical director and based on this information from Moderna, no re-vaccination is needed.
Age: 30.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: COVID-19, Exposure during pregnancy, Malaise, SARS-CoV-2 test positive
Clinical narrative: COVID-19  04/07/2021  1 of 2  Comirnaty 30mcg   COVID-19  04/28/2021  2 of 2  Comirnaty 30mcg   COVID-19  11/22/2021  3 of 2  Comirnaty 30mcg       Admitted with COVID symptoms and positive test 6/28/22. Patient is pregnant
Age: 68.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Appendicitis, Computerised tomogram abdomen abnormal, Laboratory test
Clinical narrative: Appendicitis
Age: 38.0
Sex: M
Vaccine: COVID19, FLUC4
Symptoms: Abdominal pain, Alcohol abuse, Alcoholism, COVID-19, Condition aggravated
Clinical narrative: Breakthrough covid case; Pt presented to ER with c/o abdominal pain,  nausea and vomiting. Hx of Pfizer vaccine x 3. Hospitalized at Hospital x 3 days. DX alcoholic gastritis, alcohol abuse and dependence, chronic pancreatitis, depression, DM, and covid 19. No other covid symptoms at this time. Patient hospitalized in May for pancreatitis then DC to rehab.
Age: 38.0
Sex: M
Vaccine: COVID19, FLUC4
Symptoms: Depression, Diabetes mellitus, Gastritis alcoholic, Nausea, Pancreatitis chronic
Clinical narrative: Breakthrough covid case; Pt presented to ER with c/o abdominal pain,  nausea and vomiting. Hx of Pfizer vaccine x 3. Hospitalized at Hospital x 3 days. DX alcoholic gastritis, alcohol abuse and dependence, chronic pancreatitis, depression, DM, and covid 19. No other covid symptoms at this time. Patient hospitalized in May for pancreatitis then DC to rehab.
Age: 38.0
Sex: M
Vaccine: COVID19, FLUC4
Symptoms: SARS-CoV-2 test, Vaccine breakthrough infection, Vomiting
Clinical narrative: Breakthrough covid case; Pt presented to ER with c/o abdominal pain,  nausea and vomiting. Hx of Pfizer vaccine x 3. Hospitalized at Hospital x 3 days. DX alcoholic gastritis, alcohol abuse and dependence, chronic pancreatitis, depression, DM, and covid 19. No other covid symptoms at this time. Patient hospitalized in May for pancreatitis then DC to rehab.
Age: 59.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Arthritis, Joint range of motion decreased, Magnetic resonance imaging abnormal, Periarthritis
Clinical narrative: Vaccine was given very high on the arm/shoulder and  missed the deltoid.  Pain in shoulder joint from the beginning and getting worse over the months, including reduced range of motion.  MRI results indicated inflammation and adhesive capsulitis.  Ongoing treatment with physical therapy and soon to schedule a cortisone shot.
Age: 59.0
Sex: F
Vaccine: COVID19
Symptoms: Product administered at inappropriate site, X-ray abnormal
Clinical narrative: Vaccine was given very high on the arm/shoulder and  missed the deltoid.  Pain in shoulder joint from the beginning and getting worse over the months, including reduced range of motion.  MRI results indicated inflammation and adhesive capsulitis.  Ongoing treatment with physical therapy and soon to schedule a cortisone shot.
Age: 28.0
Sex: F
Vaccine: HEP
Symptoms: Abdominal pain, Malaise, Rash, Vomiting
Clinical narrative: Patient had Hepatitis B vaccine @ 10:30 am this morning.   Around 2:00 pm this afternoon patient become ill with emesis, rash on leg, sharp pain in abdomen.    Pt has taken benadryl in the past with no reaction.  She will take for the rash on her leg.   She will alternate Tylenol and ibuprofen for her pain.  Will increase hydration.   She has no fever/chills/tongue swelling/trouble breathing-swallowing.  If she develops any worsening sxs over the night she will go to the ED.
Age: 11.0
Sex: F
Vaccine: COVID19
Symptoms: Extra dose administered
Clinical narrative: We administered the Pfizer Adult Vaccine to the 11-year-old patient, but only 0.1ML. At the time the patient came in, parents were requesting the vaccine and it was just approved and we thought we could use the Pfizer Adult vaccine but just administer half the dose. After we realize that Pfizer had a different vaccine for adults and pediatrics.   We called patient to check if patient had any reaction to vaccine, but patient was feeling good and didn't have any reaction or other symptoms.
Age: 34.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, Cough, Headache, Oropharyngeal pain, Respiratory tract congestion
Clinical narrative: Breakthrough covid case; Pt presented to ER with c/o of congestion, sore throat, cough and headache. Hx of Pfizer vaccine x 3. Prescribed Paxlovid. DC home.
Age: 34.0
Sex: M
Vaccine: COVID19
Symptoms: SARS-CoV-2 test, Vaccine breakthrough infection
Clinical narrative: Breakthrough covid case; Pt presented to ER with c/o of congestion, sore throat, cough and headache. Hx of Pfizer vaccine x 3. Prescribed Paxlovid. DC home.
Age: 91.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, Death, SARS-CoV-2 test positive
Clinical narrative: Death on 06/22/2022 at Nursing Home
Age: 62.0
Sex: M
Vaccine: COVID19
Symptoms: Dyspepsia
Clinical narrative: I didn't have any issues until 2 months after my vaccine and didn't associate it as an issue with the vaccine. But I began to have persistent heart burn and around 06/15/2022 my doctor prescribed a prescription strength PRILOSEC which has completely resolved the issue so far.
Age: 2.0
Sex: M
Vaccine: COVID19
Symptoms: Underdose, Unintentional medical device removal
Clinical narrative: RN administed Moderna COVID vaccine in Left thigh, but child's parent didn't have a hold on him and the needle came out after injecting .15mL, however, the Dad said he felt some of the injection go on his leg.  After talking to pharmacist on duty, RN and child's father, it was determined that the child received less than half of the dose and it was recommended to readminister.  Vaccine was readministered in Left deltoid successfully.
Age: 32.0
Sex: F
Vaccine: COVID19
Symptoms: Caesarean section, Complication of pregnancy, Exposure during pregnancy, Foetal anaemia, Foetal-maternal haemorrhage
Clinical narrative: I was 14 weeks and 6 days pregnant at the time of my COVID booster. This was my third pregnancy, the first resulted in a full term healthy baby, the second in a miscarriage at about 8 weeks. At the time of my booster my pregnancy was healthy with no complications. At 33 weeks and 3 days I noticed no movement of my baby and went to the doctor the following day, at which point my baby was delivered (33 weeks 4 days) via emergency caesarian due to an extremely rare pregnancy complication, a fetal maternal hemorrhage, that was causing my baby to become dangerously anemic. My baby was born weighing 2440 grams and spent 17 days in the ICU. I have no idea if this was related to the vaccine but given the rarity of the condition I wanted to report it.
Age: 9.0
Sex: M
Vaccine: COVID19
Symptoms: Incorrect dose administered, Incorrect product formulation administered, No adverse event
Clinical narrative: We administered the Pfizer Adult Vaccine to the 9yrs old patient, but only 0.1ML. At the time the patient came in, parents were requesting the vaccine and it was just approved and we thought we could use the Pfizer Adult vaccine but just administer half the dose. After we realize that Pfizer had a different vaccine for adults and pediatrics.   We called patient to check for any reaction to vaccine, but patient was feeling good and had no reaction or other symptoms.
Age: 72.0
Sex: F
Vaccine: VARZOS
Symptoms: Chills, Headache, Pyrexia, Vomiting
Clinical narrative: Chills fever nausea vomiting headache
Age: 69.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, Cough, Malaise, Nausea, Oropharyngeal pain
Clinical narrative: I tested positive for COVID on 6/1/2022.  I experienced cough, congestion, aches, sore throat, fever, aches and nausea.  Symptoms kept me in bed for 3 days, then improved over the next 4 days.  I contacted my PCP at onset of symptoms and was prescribed Paxlovid which I took for 5 days.
Age: 69.0
Sex: F
Vaccine: COVID19
Symptoms: Pain, Pyrexia, Respiratory tract congestion, SARS-CoV-2 test positive
Clinical narrative: I tested positive for COVID on 6/1/2022.  I experienced cough, congestion, aches, sore throat, fever, aches and nausea.  Symptoms kept me in bed for 3 days, then improved over the next 4 days.  I contacted my PCP at onset of symptoms and was prescribed Paxlovid which I took for 5 days.
Age: 29.0
Sex: M
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: The vaccine expiration date was identified to expire on June 22, 2021, but the manufacturer expiration date was February 25, 2021.  Based on the information learned, County Health took the following steps: ? Contacted Moderna for guidance and based on Moderna data, the Moderna Medical Information team provided the following information:  o ?The vaccine administered on March 4, 2021 through March 10, 2021 from lot number 025J20-2A maintained the activity necessary to protect against the SARS-CoV-2 (COVID-19) virus at time of administration.?  ? Contacted a county medical director and based on this information from Moderna, no re-vaccination is needed.
Age: 31.0
Sex: M
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: The vaccine expiration date was identified to expire on June 22, 2021, but the manufacturer expiration date was February 25, 2021.  Based on the information learned, County Health took the following steps: ? Contacted Moderna for guidance and based on Moderna data, the Moderna Medical Information team provided the following information:  o ?The vaccine administered on March 4, 2021 through March 10, 2021 from lot number 025J20-2A maintained the activity necessary to protect against the SARS-CoV-2 (COVID-19) virus at time of administration.?  ? Contacted a county medical director and based on this information from Moderna, no re-vaccination is needed.
Age: 56.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, Exposure to SARS-CoV-2, Headache, Influenza virus test, Oropharyngeal pain
Clinical narrative: Covid breakthrough case. Patient presented to ER on 6/22/22 with c/o of sore throat, runny nose, headache, fever, body aches and exposure to covid. Hx of Pfizer vaccine x 3. DC home.
Age: 56.0
Sex: M
Vaccine: COVID19
Symptoms: Pain, Pyrexia, Rhinorrhoea, SARS-CoV-2 test positive, Streptococcus test
Clinical narrative: Covid breakthrough case. Patient presented to ER on 6/22/22 with c/o of sore throat, runny nose, headache, fever, body aches and exposure to covid. Hx of Pfizer vaccine x 3. DC home.
Age: 56.0
Sex: M
Vaccine: COVID19
Symptoms: Vaccine breakthrough infection
Clinical narrative: Covid breakthrough case. Patient presented to ER on 6/22/22 with c/o of sore throat, runny nose, headache, fever, body aches and exposure to covid. Hx of Pfizer vaccine x 3. DC home.
Age: 27.0
Sex: M
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: The vaccine expiration date was identified to expire on June 22, 2021, but the manufacturer expiration date was February 25, 2021.  Based on the information learned, County Health took the following steps: ? Contacted Moderna for guidance and based on Moderna data, the Moderna Medical Information team provided the following information:  o ?The vaccine administered on March 4, 2021 through March 10, 2021 from lot number 025J20-2A maintained the activity necessary to protect against the SARS-CoV-2 (COVID-19) virus at time of administration.?  ? Contacted a county medical director and based on this information from Moderna, no re-vaccination is needed.
Age: 50.0
Sex: M
Vaccine: COVID19
Symptoms: Arthralgia, Bursitis, Drug hypersensitivity
Clinical narrative: This might or might not be connected to the COVID19 vaccination, however that is a new condition that I did not have ever before. I went to a doctor on May 31st as I had shoulder pain and was diagnosed with bursitis. The doctor recommended a steroid injection (Kenalog) to cure this. I had a steroid injection before without any adverse reaction, so I was fine with it. Shortly after this I had a very strong allergic reaction, rash all over the body, swollen face and starting trouble breathing,  so I had to go to the ER. They treated the condition and it has not occured after again. However I just learned from a friend that he had a similar issue with a new allergic reaction that he never had before so he had so see the ER (and he was vaccinated with Pfizer as well while I don't have his details to share), so maybe this is indeed connected to the vaccination.  I will definitely have myself re-tested for allergies to be prepared. Also I was prescribed  an EpiPen for emergencies
Age: 26.0
Sex: F
Vaccine: HEPA, MMR, TDAP, UNK
Symptoms: Expired product administered
Clinical narrative: Patient was given a Havrix, manufactured by GlaxoSmithKline, on 6/20/2022. The expiration date for this vaccine was 6/18/2022. Patient is not having any adverse reaction or symptoms. I am required to report this immunization error. GSK and CDC were contacted to confirm that patient's  health is not in any danger. This was confirmed and GSK stated the potency/viability for this vaccine extends up to 30 days past expiration date. No further action needed.
Age: 11.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, Cough, Headache, Influenza virus test, Pain
Clinical narrative: Breakthrough covid case; Pt presented to ER on 6/22/22 with c/o runny nose headache, fever, body aches and cough x 2 days. Father is also symptomatic. Hx of Pfizer vaccine x 2. DC home.
Age: 11.0
Sex: F
Vaccine: COVID19
Symptoms: Pyrexia, Rhinorrhoea, SARS-CoV-2 test positive, Streptococcus test, Vaccine breakthrough infection
Clinical narrative: Breakthrough covid case; Pt presented to ER on 6/22/22 with c/o runny nose headache, fever, body aches and cough x 2 days. Father is also symptomatic. Hx of Pfizer vaccine x 2. DC home.
Age: 63.0
Sex: F
Vaccine: COVID19
Symptoms: Anosmia, Chest pain, Dyspnoea
Clinical narrative: 2/18/2021: Lost complete ability to smell anything within 24 hours of receiving the vaccination - as of today, 6/28/2022, I still cannot smell anything 2/18/2021: I had sharp chest pains when drawing a breath and shortness of breath until 9/21/2021
Age: 74.0
Sex: F
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: Pfizer vaccine was administered to the patient that had an expiration date of 5/10/22. Since this vaccine was within the 72 day time frame the vaccine did not have to be repeated.
Age: 61.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, Death, SARS-CoV-2 test positive
Clinical narrative: Suspected MI prior to Death on  06/10/2022- time frame unknown
Age: 56.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, SARS-CoV-2 test positive
Clinical narrative: I tested positive for COVID-19 13 days after receiving my 4th dose of Moderna
Age: 84.0
Sex: M
Vaccine: COVID19
Symptoms: Cardiac failure, Condition aggravated, Death, Intensive care
Clinical narrative: Patient was en route to the ER but visited the pharmacy before getting admitted for symptomatic heart failure. Patient was then transferred to the ICU for exacerbated heart failure and passed two weeks later in his sleep.
Age: 95.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Unevaluable event
Clinical narrative: patient hospitalized
Age: 75.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, Exposure to SARS-CoV-2, Fatigue, Rhinorrhoea, SARS-CoV-2 test positive
Clinical narrative: Breakthrough covid case. Patient tested positive at local Health Clinic on 6/22/22 with c/o runny nose, fatigue and covid exposure x 2 days.
Age: 75.0
Sex: M
Vaccine: COVID19
Symptoms: Vaccine breakthrough infection
Clinical narrative: Breakthrough covid case. Patient tested positive at local Health Clinic on 6/22/22 with c/o runny nose, fatigue and covid exposure x 2 days.
Age: 61.0
Sex: M
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: A grey cap Pfizer vaccine was opened and punctured on 6/24/22. This same vial was used to vaccinate this individual on 6/27/22, past the 12 hour limit on grey caps after puncturing.
Age: 64.0
Sex: F
Vaccine: COVID19
Symptoms: Full blood count, Platelet count decreased
Clinical narrative: the patient had been on of immunosuppressive dose of acyclovir for his herpes zoster in infection.   He then went to the local pharmacy to have a shingles vaccine on June 6th or 7th of 2022  1 week later on 06/15/2022 the patient went to the Pharmacy and got the 3rd COVID vaccination which was his booster  he then ended up in our emergency room with less than 2000 platelet counts.
Age: 43.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, Ear pain, Myalgia, Oropharyngeal pain, Respiratory tract congestion
Clinical narrative: Breakthrough covid case. Patient presented to ER on 6/22/22 with c/o of runny nose, congestion, sore throat, ear pain and myalgia. Hx of Moderna vaccine x 2 doses. DC home.
Age: 43.0
Sex: F
Vaccine: COVID19
Symptoms: Rhinorrhoea, SARS-CoV-2 test, Streptococcus test, Vaccine breakthrough infection
Clinical narrative: Breakthrough covid case. Patient presented to ER on 6/22/22 with c/o of runny nose, congestion, sore throat, ear pain and myalgia. Hx of Moderna vaccine x 2 doses. DC home.
Age: 88.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Unevaluable event
Clinical narrative: patient hospitalized
Age: 22.0
Sex: M
Vaccine: TDAP
Symptoms: Pallor, Tremor
Clinical narrative: upon administration of Adacel vaccine, very pale, began to shake for about 15-30seconds. Did not lose consciousness able to communicate. Stated he is fine, he is okay.
Age: 9.0
Sex: M
Vaccine: COVID19
Symptoms: Incorrect dose administered, Product administered to patient of inappropriate age
Clinical narrative: On 6/27/22 9 year old pt received a Moderna Magenta dose of Covid 19.  Spoke/emailed CDC Ask the Experts as well as Moderna.  Both stated pt can come in and receive the age appropriate Covid 19 vaccine.  We do not have Moderna Teal as of yet so if pt can come in soon pt would receive Pfizer for 5-11 year old.  Or can wait unit we receive Moderna Teal.  Spoke mother on 6/28 informed her of the incident, mother calm and understanding.  Informed her of the 2 options that were advised.  Mom states she will need to speak with dad and call us to let us know what they decide.  Also, left a voicemail on dads number to call clinic.  No treatment is needed, will have to start Covid 19 vaccine over.
Age: 56.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, Chills, Cough, Headache, Influenza virus test
Clinical narrative: Covid breakthrough case. Pt presented to ER on 6/23/22 with c/o chills, runny nose, congestion, headache, cough and body aches x 1 day. Hx of moderna vaccine x 2 doses. DC home.
Age: 56.0
Sex: F
Vaccine: COVID19
Symptoms: Pain, Respiratory tract congestion, Rhinorrhoea, SARS-CoV-2 test, Vaccine breakthrough infection
Clinical narrative: Covid breakthrough case. Pt presented to ER on 6/23/22 with c/o chills, runny nose, congestion, headache, cough and body aches x 1 day. Hx of moderna vaccine x 2 doses. DC home.
Age: 86.0
Sex: M
Vaccine: COVID19
Symptoms: Defaecation urgency, Diarrhoea, Erectile dysfunction, Frequent bowel movements, Functional gastrointestinal disorder
Clinical narrative: Patient reports ongoing gastrointestinal dysfunction with frequent, loose, and urgent stooling.  Has been placed on Metamucil which has decreased frequency but has not improved urgency or consistency of stooling.  Symptoms came on 2 weeks after receiving his 5th dose of the Pfizer vaccination.  Date was verified with the patient's vaccine card.  He has also reported erectile dysfunction and decreased libido since this booster was received.  No changes were previously made to his medical regimen to his recollection or according to my available records.
Age: 86.0
Sex: M
Vaccine: COVID19
Symptoms: Libido decreased
Clinical narrative: Patient reports ongoing gastrointestinal dysfunction with frequent, loose, and urgent stooling.  Has been placed on Metamucil which has decreased frequency but has not improved urgency or consistency of stooling.  Symptoms came on 2 weeks after receiving his 5th dose of the Pfizer vaccination.  Date was verified with the patient's vaccine card.  He has also reported erectile dysfunction and decreased libido since this booster was received.  No changes were previously made to his medical regimen to his recollection or according to my available records.
Age: 47.0
Sex: M
Vaccine: COVID19, HEPAB, TDAP
Symptoms: Expired product administered
Clinical narrative: A Pfizer grey cap COVID-19 vaccine was given on 6/27/22, but this vial had previously been opened and punctured on 6/24/22. This puts the vaccine given on 6/27/22 past the 12 hour window that it can be used after puncturing.
Age: 66.0
Sex: M
Vaccine: VARZOS
Symptoms: Extra dose administered
Clinical narrative: Patient received a 3rd dose of Shingrix, after getting  2 doses in 2019 on 07/12/2019 and 09/16/2019. Patient states he had no issues at all, thought it was important to report the discrepancy.
Age: 64.0
Sex: M
Vaccine: COVID19, FLUC4, COVID19, FLU4
Symptoms: COVID-19, Cough, Pain, Rhinorrhoea, SARS-CoV-2 test
Clinical narrative: Breakthrough covid case; Pt presented to ER on 6/24/22 with c/o sinus drainage, cough, body aches. Hx of Pfizer vaccine x 3 doses. Pt recently traveled. DC home.
Age: 64.0
Sex: M
Vaccine: COVID19, FLUC4, COVID19, FLU4
Symptoms: Vaccine breakthrough infection
Clinical narrative: Breakthrough covid case; Pt presented to ER on 6/24/22 with c/o sinus drainage, cough, body aches. Hx of Pfizer vaccine x 3 doses. Pt recently traveled. DC home.
Age: 64.0
Sex: M
Vaccine: COVID19, FLUC4, COVID19, FLU4
Symptoms: COVID-19, Cough, Pain, Paranasal sinus hypersecretion
Clinical narrative: Breakthrough covid case; Pt presented to ER on 6/24/22 with c/o sinus drainage, cough, body aches. Hx of Pfizer vaccine x 3 doses. Pt recently traveled. DC home.
Age: 82.0
Sex: F
Vaccine: COVID19
Symptoms: Dizziness, Hypotonia, Syncope, Unresponsive to stimuli
Clinical narrative: after moderna 2nd booster vaccination , the patient felt lightheaded and requested some water. We gave her bottle of water and she was sitting in chair and then she dropped her water bottle and her head fell back and Rph asked if she was ok. She did not respond right away and was just staring and not able to respond so the staff called emergency. When the EMT arrived the patient was beginning to be aware of her surroundings and what was going on and was embarrassed she "fainted". The EMT checked her vitals etc, and she was able to leave on her own.
Age: 3.0
Sex: F
Vaccine: COVID19
Symptoms: Incorrect dose administered, Product preparation issue
Clinical narrative: Patient was given a 0.2 ml dose that was not diluted.
Age: 47.0
Sex: M
Vaccine: COVID19
Symptoms: Expired product administered, No adverse event
Clinical narrative: patient received expired medication. confirmed with manufacturer that dose maintained its efficacy. no follow-up needed. no adverse outcome
Age: 56.0
Sex: M
Vaccine: COVID19
Symptoms: Expired product administered, No adverse event
Clinical narrative: patient received expired medication. confirmed with manufacturer that dose maintained its efficacy. no follow-up needed. no adverse outcome
Age: 16.0
Sex: M
Vaccine: MNQ
Symptoms: Cerebral ventricle dilatation, Computerised tomogram head abnormal, Generalised tonic-clonic seizure
Clinical narrative: tonic clonic generalized seizure about 14 hours after vaccination administration
Age: 52.0
Sex: F
Vaccine: COVID19, FLUC4
Symptoms: Ageusia, Anosmia, COVID-19, Cough, Dyspnoea
Clinical narrative: Breakthrough covid case. Pt presented to ER on 6/25/22 with c/o nasal congestion, loss of smell and taste, cough, sob and fever. Pt test positive in 1/2022. Hx of Moderna vaccine x 3 doses. Prescribed Paxlovid. DC home.
Age: 52.0
Sex: F
Vaccine: COVID19, FLUC4
Symptoms: Influenza virus test, Nasal congestion, Pyrexia, SARS-CoV-2 test, Streptococcus test
Clinical narrative: Breakthrough covid case. Pt presented to ER on 6/25/22 with c/o nasal congestion, loss of smell and taste, cough, sob and fever. Pt test positive in 1/2022. Hx of Moderna vaccine x 3 doses. Prescribed Paxlovid. DC home.
Age: 52.0
Sex: F
Vaccine: COVID19, FLUC4
Symptoms: Urine analysis, Vaccine breakthrough infection
Clinical narrative: Breakthrough covid case. Pt presented to ER on 6/25/22 with c/o nasal congestion, loss of smell and taste, cough, sob and fever. Pt test positive in 1/2022. Hx of Moderna vaccine x 3 doses. Prescribed Paxlovid. DC home.
Age: 1.33
Sex: F
Vaccine: COVID19
Symptoms: Abnormal behaviour, Body temperature increased, Lethargy, Oxygen saturation decreased, Pyrexia
Clinical narrative: The day following her first does of the COVID-19 vaccine We were battling fevers up and down all day but right before we put her to bed, she was behaving abnormally and was very lethargic. We kept her up until we were able to give her another dose of TYLENOL. When we put her to bed, we put her pulse oxygen monitor on. While she was sleeping her levels dropped into the 70's. When we went to check on her, she was not responding in the way we had hoped. Her temperature was at 103.5 and it is believed that she had a fever induced seizure. Paramedics came to our home and we noticed that she was unresponsive and they advised that we take her directly to the emergency room. Once she was evaluated at the emergency room they gave her a dose of ibuprofen as her temperature was still elevated. They monitored her for an hour or so after that and determined that she was safe to be sent home. She continued to run fevers for a few days after and is finally getting back to normal levels as of today 06.28.
Age: 1.33
Sex: F
Vaccine: COVID19
Symptoms: Seizure, Unresponsive to stimuli
Clinical narrative: The day following her first does of the COVID-19 vaccine We were battling fevers up and down all day but right before we put her to bed, she was behaving abnormally and was very lethargic. We kept her up until we were able to give her another dose of TYLENOL. When we put her to bed, we put her pulse oxygen monitor on. While she was sleeping her levels dropped into the 70's. When we went to check on her, she was not responding in the way we had hoped. Her temperature was at 103.5 and it is believed that she had a fever induced seizure. Paramedics came to our home and we noticed that she was unresponsive and they advised that we take her directly to the emergency room. Once she was evaluated at the emergency room they gave her a dose of ibuprofen as her temperature was still elevated. They monitored her for an hour or so after that and determined that she was safe to be sent home. She continued to run fevers for a few days after and is finally getting back to normal levels as of today 06.28.
Age: 51.0
Sex: M
Vaccine: COVID19
Symptoms: Expired product administered, No adverse event
Clinical narrative: patient received expired medication. confirmed with manufacturer that dose maintained its efficacy. no follow-up needed. no adverse outcome
Age: 71.0
Sex: F
Vaccine: COVID19
Symptoms: Chest X-ray normal, Dyspnoea, Electrocardiogram normal
Clinical narrative: difficulty taking a very deep breath, not short of breath.  came on slowly but every day starting on  July 15th.
Age: 72.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, Malaise, Nasopharyngitis, Pyrexia, Respiratory tract congestion
Clinical narrative: COVID-19 I received my 2nd booster shot on 05/25/2022 and my COVID symptoms  started on 06/18/2022 congestion, sneezing, fever. I  felt like  i had a bad cold. I had no cough or sore throat. I tested on the 06/19/2022 positive.  I did a telehealth on 06/20/222 with my doctor.  She gave me prescription for PAXLOVID.  I also took Benadryl r 2 nights.  I took COVID test again on the 06/20/2022.
Age: 72.0
Sex: F
Vaccine: COVID19
Symptoms: SARS-CoV-2 test positive, Sneezing
Clinical narrative: COVID-19 I received my 2nd booster shot on 05/25/2022 and my COVID symptoms  started on 06/18/2022 congestion, sneezing, fever. I  felt like  i had a bad cold. I had no cough or sore throat. I tested on the 06/19/2022 positive.  I did a telehealth on 06/20/222 with my doctor.  She gave me prescription for PAXLOVID.  I also took Benadryl r 2 nights.  I took COVID test again on the 06/20/2022.
Age: 52.0
Sex: F
Vaccine: COVID19
Symptoms: Breast cancer female, Breast mass
Clinical narrative: Patient self palpated a right breast mass, ended up being breast cancer.  Needing chemo and surgery
Age: 13.0
Sex: M
Vaccine: COVID19, HEP
Symptoms: Pyrexia, Seizure
Clinical narrative: seizures for 3 days in a row (Sat, Sun, and today, when he has not had any seizures for a few months. Had to administer emergency seizure medication (Lorazepam) as the seizures persisted past the 2  minute mark on 2 out of 3 of the days.  He has had persistent fever from day after shot (6/24/22) to the present day (6/28/22). Consistently 101.8.  Fever spiking at times to between 104.9 and 105.3 even after ibuprofen given. Has happened early in the morning, so it is unknown at point if it will continue to happen. If fever spikes high again  doctor says to go to ER.
Age: 0.17
Sex: M
Vaccine: UNK
Symptoms: Wrong product administered
Clinical narrative: No symptoms at this time- a Varicella vaccine was given by the MA instead of Vaxelis
Age: 84.0
Sex: M
Vaccine: COVID19
Symptoms: Expired product administered, No adverse event
Clinical narrative: patient received expired medication. confirmed with manufacturer that dose maintained its efficacy. no follow-up needed. no adverse outcome
Age: 68.0
Sex: M
Vaccine: COVID19, UNK
Symptoms: Abdominal distension, COVID-19, Chest discomfort, Chest pain, Cough
Clinical narrative: A couple of weeks after taking the vaccine, I suffered from a break through case of COVID-19. The first weeks it just felt like a cold that went away for a few days and then came back stronger. I took an at home test and came back positive. I suffered from fuzzy head, body aches, headaches, very tired, and a cough that hurt. I spoke to my doctor and gave me Paxlovid. I felt better within a few days but then started having chest problems. I did a remote urgent care and they told me to go to the ER because they were concerned with chest pain. I went into the clinic instead because I did not have heart attack symptoms that I feared going to the ER. They did an EKG and vitals and everything looked good. I had really abnormal GI symptoms. I had no appetite, a metallic taste, and was very bloated. I am still suffering from sore throat symptoms and my voice is raspy, and I still have upper congestion and it all manifests during the evening and I wake up with a cough everyday however it gets slightly better as the day progresses.